| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 05/10/2011 | US7939106 Surface stabilized fenofibrate particles have a particle size of 10 mu m or less; phospholipid surface modifier; dispersed in a bulking/ releasing matrix |
| 05/10/2011 | US7939105 Rapidly dispersing solid dry therapeutic dosage |
| 05/10/2011 | CA2419633C Substituted imidazoles as tafia inhibitors |
| 05/10/2011 | CA2418815C Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative |
| 05/10/2011 | CA2292898C Bacterial pheromones and uses therefor |
| 05/05/2011 | US20110104315 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 05/05/2011 | US20110104170 Novel composition and methods for the treatment of immune related diseases |
| 05/05/2011 | US20110100361 Pressurised metered dose inhalers (mdi) |
| 05/04/2011 | EP2316493A2 Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 05/04/2011 | EP2316479A2 Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments |
| 05/04/2011 | CN102038938A Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-beta |
| 05/03/2011 | US7935724 Thiophene and benzothiophene hydroxamic acid derivatives |
| 05/03/2011 | US7935698 Heteroaryl-hydrazone compounds |
| 05/03/2011 | US7935692 Polyamine compounds are used to mobilize and harvest CD34+ cells via apheresis with and without combinations with other mobilizing factors; bind to chemokine receptors; regeneration of heart tissue |
| 05/03/2011 | CA2518219C Igf-binding protein-derived peptide or small molecule |
| 04/28/2011 | US20110098504 Histone Deacetylase Inhibitors and Methods of Use Thereof |
| 04/28/2011 | US20110097362 Transmucosal Administration of Aggregated Antigens |
| 04/28/2011 | US20110097306 Oral formulations of cladribine |
| 04/27/2011 | EP2314676A1 Compositions and methods for the treatment of immune related diseases |
| 04/27/2011 | EP2314315A1 A blocking monoclonal antibody to the human alpha1 I-domain of VLA-1, and its use for the treatment of inflammatory disorders |
| 04/27/2011 | EP2314313A1 Vaccine against streptococcus pneumoniae |
| 04/27/2011 | EP1589998B1 IL-27 and IL-2 for use in the treatment of cancer |
| 04/27/2011 | EP1578325B1 Stable topical drug delivery compositions |
| 04/27/2011 | CN1810802B 3-substituted-4-pyrimidone derivatives |
| 04/26/2011 | US7932365 Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use |
| 04/26/2011 | US7932364 Extended half life; reduced clearance and immunogenicity; industrial scale production; cells, expression cassettes |
| 04/26/2011 | US7932290 Method for the treatment of metabolic disorders |
| 04/26/2011 | US7931915 Extended release venlafaxine formulation |
| 04/26/2011 | CA2543350C Disintegratable films for diagnostic devices |
| 04/21/2011 | US20110092694 Synthesis of 5-azacytidine |
| 04/20/2011 | EP2311973A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/20/2011 | EP2311870A1 Compositions and methods for the treatment of immune related diseases |
| 04/20/2011 | EP2311868A1 Compositions and methods for the treatment of immune related diseases |
| 04/20/2011 | EP2311850A1 Anti-cancer cyclopenta[g]quinazoline compounds |
| 04/20/2011 | EP2311825A1 Pyrimidineamines as angiogenesis modulators |
| 04/20/2011 | EP1680140B1 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof |
| 04/20/2011 | EP1639141B1 Methods for treating lentivirus infections |
| 04/20/2011 | EP1624892B1 Therapeutic use of anti-cs1 antibodies |
| 04/20/2011 | EP1603887B1 Hiv replication inhibiting indane substituted pyrimidines |
| 04/20/2011 | CN102020697A Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication |
| 04/19/2011 | US7928284 Methods and animal model for analyzing age-related macular degeneration |
| 04/19/2011 | US7928069 Crosslinked compounds and methods of making and using thereof |
| 04/19/2011 | US7927870 DNA vaccine formulations |
| 04/19/2011 | US7927626 Biocompatible liquid, biocompatible gas, and solid particles of a biocompatible polymer are mixed together to form a homogenous composition including a discontinuous gas phase with solid particles homogenously dispersed throughout a continuous liquid phase |
| 04/19/2011 | US7927579 Tandem analyses of noncovalently driven effectors for modulatory mapping of activities of protein sites |
| 04/19/2011 | CA2539853C Isoquinolinone potassium channel inhibitors |
| 04/14/2011 | US20110086046 Treatment of MS with goat serum |
| 04/13/2011 | EP2308968A1 Compositions and methods for the treatment of immune related diseases |
| 04/13/2011 | EP2308502A1 Method to induce neovascular formation and tissue regeneration |
| 04/13/2011 | EP2308479A2 Compounds and compositions for delivering active agents |
| 04/13/2011 | EP1639109B1 Dna vectors |
| 04/13/2011 | EP1140085B1 Azabicycloalkanes as ccr5 modulators |
| 04/13/2011 | CN1665488B Direct cellular energy delivery system |
| 04/13/2011 | CN101238895B Nutrition replenisher for JUCARA and ACAI fruit group |
| 04/12/2011 | US7923560 Delivery of immune response modifier compounds |
| 04/12/2011 | US7923448 Purine receptor inhibition as a therapeutic strategy in spinal cord and brain |
| 04/12/2011 | US7923230 Neurodegenerative protein aggregation inhibition methods and compounds |
| 04/12/2011 | US7923040 Homeopathic formulations useful for treating pain and/or inflammation |
| 04/12/2011 | US7923010 Methods and materials for treating autoimmune diseases and conditions |
| 04/12/2011 | CA2528496C Acylated amino acid amidyl pyrazoles and related compounds |
| 04/12/2011 | CA2526771C Synthesis of high molecular weight iron-saccharidic complexes |
| 04/12/2011 | CA2522435C Inhibitors of akt activity |
| 04/07/2011 | US20110081359 Alpha 5 beta 1 and its ability to regulate the cell survival pathway |
| 04/07/2011 | US20110081292 Methods Of Treating Viral Hepatitis |
| 04/06/2011 | EP2305708A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 04/06/2011 | EP2305707A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 04/06/2011 | EP2305706A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 04/06/2011 | EP2305298A1 Vaccine against streptococcus pneumoniae |
| 04/06/2011 | EP2305297A1 Vaccine against streptococcus pneumoniae |
| 04/06/2011 | EP2305267A2 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
| 04/06/2011 | EP2305253A1 Use of pramipexole to treat amyotrophic lateral sclerosis |
| 04/06/2011 | EP2305252A1 Use of pramipexole to treat amyotrophic lateral sclerosis |
| 04/06/2011 | EP1485056B1 Methods of using fet labeled oligonucleotides that include a'5' exonuclease resistant quencher domain and compositions for practicing the same |
| 04/06/2011 | CN1902158B N,N-dihalogenated amino acids and derivatives |
| 04/06/2011 | CN102000336A Carbostyril derivatives and mood stabilizers for treating mood disorders |
| 04/05/2011 | CA2474479C Composition for inhalation |
| 03/31/2011 | US20110077399 Substituted Azole Derivatives as Therapeutic Agents |
| 03/31/2011 | US20110077266 Diamine Derivatives |
| 03/31/2011 | US20110077233 C-Met Modulators and Method of Use |
| 03/30/2011 | EP2301966A1 Immunoglobulin variants and uses thereof |
| 03/30/2011 | EP2301573A1 Anti-cancer and anti-infectious disease compositions and methods for using same |
| 03/30/2011 | EP2301566A1 DNA vaccines encoding heat shock proteins |
| 03/30/2011 | EP2301564A1 Compositions and methods for promoting neuronal outgrowth |
| 03/30/2011 | EP2301542A1 Controlled-release compositions containing opioid agonist and antagonist |
| 03/30/2011 | EP2301530A1 Use of a fatty acid composition comprising EPA and DHA for reducing body weight |
| 03/30/2011 | EP1622579B1 Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin |
| 03/30/2011 | EP1517710B1 Pegylated factor vii glycoforms |
| 03/29/2011 | US7915393 Compositions and methods for WT1 specific immunotherapy |
| 03/29/2011 | US7915265 Combinations for the treatment of immunoinflammatory disorders |
| 03/29/2011 | US7915254 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
| 03/29/2011 | US7915234 Pharmaceutically active uridine esters |
| 03/29/2011 | CA2468715C Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 03/29/2011 | CA2397016C Use of lipid conjugates in the treatment of disease |
| 03/29/2011 | CA2299139C 4-phenyl-pyridine derivatives |
| 03/24/2011 | US20110071203 Transmucosal veterinary composition comprising detomidine |
| 03/24/2011 | US20110071137 Process for preparing sustained release tablets |
| 03/24/2011 | US20110071095 Compositions and Methods for Increasing Telomerase Activity |
| 03/24/2011 | US20110070644 Monocyte-Derived Stem Cells (MDSC) and Methods of Use Thereof |
| 03/24/2011 | US20110070203 Mesendoderm and mesoderm cell populations |
| 03/24/2011 | US20110070155 Anti-CD74 Immunoconjugates and Methods |